After five of the 11 nominees for the Civilian Review Board were nearly unanimously voted down, community members have mixed feelings regarding the process of the board’s establishment. Last January, ...
Data to be presented for 167 enrolled participants of which 122 were evaluable for efficacy Company to host HNSCC KOL event to review and discuss data NORWOOD, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- ...
Corbus Pharmaceuticals initiates combination cohort of CRB-701 study for solid tumors, focusing on HNSCC and cervical cancer. Data update expected this year. Corbus Pharmaceuticals Holdings, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback